secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2023-10-04T23:59:59+00:00
Accession:  0001683168-23-006959
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon completes 1-for-10 reverse stock split to maintain Nasdaq listing
-------------------------------------------------------------------------

- Reverse stock split approved by stockholders and board; ratio 1-for-10.
- Effective 5:00 p.m. ET on October 4, 2023; trading begins on split-adjusted basis October 5.
- Post-split outstanding shares approximately 2.5 million; new CUSIP 00808Y406.
- Purpose: meet Nasdaq minimum bid price requirement and continue capital market access.
- No fractional shares issued; stockholders receive full share for any fractional interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316823006959/0001683168-23-006959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316823006959/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-006959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer